Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:137918005" > Surgical management...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03784naa a2200409 4500 | |
001 | oai:prod.swepub.kib.ki.se:137918005 | |
003 | SwePub | |
008 | 240811s2018 | |||||||||||000 ||eng| | |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1379180052 URI |
024 | 7 | a https://doi.org/10.1093/dote/dox1462 DOI |
040 | a (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Mege, D4 aut |
245 | 1 0 | a Surgical management of esophageal sarcoma: a multicenter European experience |
264 | c 2018-02-09 | |
264 | 1 | b Oxford University Press (OUP),c 2018 |
520 | a Esophageal sarcomas are rare and evidence in literature is scarce making their management difficult. The objective is to report surgical and oncological outcomes of esophageal sarcoma in a large multicenter European cohort. This is a retrospective multicenter study including all patients who underwent en-bloc esophagectomy for esophageal sarcoma in seven European tertiary referral centers between 1987 and 2016. The main outcomes and measures are pathological results, early and long-term outcomes. Among 10,936 esophageal resections for cancer, 21 (0.2%) patients with esophageal sarcoma were identified. The majority of tumors was located in the middle (n = 7) and distal (n = 9) third of the esophagus. Neoadjuvant chemoradiotherapy was performed in five patients. All the patients underwent en-bloc transthoracic esophagectomy (19 open, 2 minimally invasive). Postoperative mortality occurred in 1 patient (5%). One patient received adjuvant chemotherapy. Definitive pathological results were carcinosarcoma (n = 7), leiomyosarcoma (n = 5), and other types of sarcoma (n = 9). Microscopic R1 resection was present in one patient (5%) and seven patients (33%) had positive lymph nodes. Median follow-up was 16 (3–79) months in 20 of 21 patients (95%). One-, 3-, and 5-year overall survival rates were 74%, 43%, and 35%, respectively. One-, 3- and 5-years disease-free survival rates were 58%, 40%, and 33%, respectively. Median overall survival was 6 months in N+ patients vs. 37 months for N0 patients (p = 0.06). At the end of the follow-up period, nine patients had died from cancer recurrences (43%), three patients died from other reasons (14%), one patient was still alive with recurrence (5%) and the seven remaining patients were free of disease (33%). Recurrence was local (n = 3), metastatic (n = 3), or both (n = 4). In conclusion, carcinosarcoma and leiomyosarcoma were the most common esophageal sarcoma histological subtypes. Lymph node involvement was seen in one third of cases. A transthoracic en-bloc esophagectomy with radical lymphadenectomy should be the best surgical option to achieve complete resection. Long-term survival remained poor with a high local and distant recurrence rate. | |
700 | 1 | a Depypere, L4 aut |
700 | 1 | a Piessen, G4 aut |
700 | 1 | a Slaman, AE4 aut |
700 | 1 | a Wijnhoven, BPL4 aut |
700 | 1 | a Holscher, A4 aut |
700 | 1 | a Nilsson, Mu Karolinska Institutet4 aut |
700 | 1 | a Henegouwen, MIV4 aut |
700 | 1 | a van Lanschot, JJB4 aut |
700 | 1 | a Schroeder, W4 aut |
700 | 1 | a Thomas, PA4 aut |
700 | 1 | a Nafteux, P4 aut |
700 | 1 | a D'Journo, XB4 aut |
710 | 2 | a Karolinska Institutet4 org |
773 | 0 | t Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagusd : Oxford University Press (OUP)g 31:3q 31:3x 1442-2050 |
773 | 0 | t Diseases of the Esophagusd : Oxford University Press (OUP)g 31:3q 31:3x 1120-8694 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:137918005 |
856 | 4 8 | u https://doi.org/10.1093/dote/dox146 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.